| Name | Title | Contact Details |
|---|
Melinta Therapeutics, Inc., an antibiotics company, is engaged in the discovery, development, and commercialization of antibiotics to overcome drug-resistant, life-threatening infections. It develops Delafloxacin, a fluoroquinolone for acute bacterial skin and skin structure infections caused by Gram-positive and Gram-negative bacteria. Melinta Therapeutics, Inc. was formerly known as formerly Rib-X Pharmaceuticals and changed its name to Melinta Therapeutics, Inc. on October 7, 2013. The company was founded in 2000 and is headquartered in New Haven, Connecticut with an additional office in Lincolnshire, Illinois.
Mederi Therapeutics is a Greenwich, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Alnylam is developing an entirely new class of innovative medicines based on a breakthrough discovery in biology known as RNA interference, or RNAi. With RNAi technology, we have the opportunity to treat disease and impact the lives of patients in a fundamentally new way by silencing disease-causing genes upstream of today`s medicines.
Avanti Polar Lipids is a Alabaster, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Huntington Medical Group P C is a Huntington Station, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.